Standards of care in diagnosis and testing for hereditary colon cancer.

Abstract:

:Inherited colorectal cancer predisposition involves a rather heterogeneous range of rare, yet relatively well-defined disorders, including Familial Adenomatous Polyposis (FAP), Hereditary Non-polyposis Colorectal Cancer (HNPCC) or Lynch syndrome, Peutz-Jeghers syndrome, Juvenile Polyposis, and their respective variants. Due to their individual rarity and highly specialized genetic diagnostic and management demands, patients and families are often seen in tertiary referral centers. For the practitioner encountering a patient suspected of having one of these conditions, guidance is usually necessary. Fortunately, detailed clinical practice guidelines have been promulgated by leading medical specialty societies. Such guidelines, which specifically do include these conditions, have the effect of codifying best or recommended approaches. It is not clear that such guidelines actually codify standards of care. To the extent such guidelines enunciate a standard of care, their impact on the legal process remains largely undefined. Because clinical practice guidelines are readily available to patients and lawyers alike through easily accessible websites, practitioners may expect to be increasingly held accountable for departing from such guidelines. Since the medical-legal implications are evident, we expect these guidelines to impact the management of familial cancer, even in the persistent absence of clear precedents in the medical malpractice arena. This paper undertakes to provide practitioners and academics some perspective on clinical practice guidelines and their potential for medical-legal application.

journal_name

Fam Cancer

journal_title

Familial cancer

authors

Lynch PM

doi

10.1007/s10689-007-9159-3

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

65-72

issue

1

eissn

1389-9600

issn

1573-7292

journal_volume

7

pub_type

杂志文章
  • Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.

    abstract::Until recently, no prediction models for Lynch syndrome (LS) had been validated for PMS2 mutation carriers. We aimed to evaluate MMRpredict and PREMM5 in a clinical cohort and for PMS2 mutation carriers specifically. In a retrospective, clinic-based cohort we calculated predictions for LS according to MMRpredict and P...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-017-0039-1

    authors: Goverde A,Spaander MCW,Nieboer D,van den Ouweland AMW,Dinjens WNM,Dubbink HJ,Tops CJ,Ten Broeke SW,Bruno MJ,Hofstra RMW,Steyerberg EW,Wagner A

    更新日期:2018-07-01 00:00:00

  • Evolution of the nomenclature for the hereditary colorectal cancer syndromes.

    abstract::The hereditary forms of colorectal cancer have been given many names historically as the manifestations have been gradually understood. Lynch syndrome has had several names, most prominently 'Hereditary Nonpolyposis Colorectal Cancer' or HNPCC. Clarification of the genetic basis and full phenotypic expression of this ...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-4489-x

    authors: Boland CR

    更新日期:2005-01-01 00:00:00

  • Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.

    abstract::PTCH1 and SUFU are both regulators of the sonic hedgehog signalling pathway. Germline inactivating mutations in both genes are associated with multisystem phenotypes including medulloblastoma. Somatic inactivating mutations in PTCH1 and SUFU each occur in approximately 10% of medulloblastomas. Recently, SUFU mutations...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9411-0

    authors: Slade I,Murray A,Hanks S,Kumar A,Walker L,Hargrave D,Douglas J,Stiller C,Izatt L,Rahman N

    更新日期:2011-06-01 00:00:00

  • Discovery of mutations in homologous recombination genes in African-American women with breast cancer.

    abstract::African-American women are more likely to develop aggressive breast cancer at younger ages and experience poorer cancer prognoses than non-Hispanic Caucasians. Deficiency in repair of DNA by homologous recombination (HR) is associated with cancer development, suggesting that mutations in genes that affect this process...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-017-0036-4

    authors: Ding YC,Adamson AW,Steele L,Bailis AM,John EM,Tomlinson G,Neuhausen SL

    更新日期:2018-04-01 00:00:00

  • Gonadal mosaicism and familial adenomatous polyposis.

    abstract::De novo mutations in the adenomatous polyposis coli (APC) gene are estimated to constitute approximately 25% of familial adenomatous polyposis (FAP) cases. A small percentage of these arise in the mosaic form, affecting only a subset of cells in the affected individual. A family is described here whereby an unaffected...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9169-1

    authors: Schwab AL,Tuohy TM,Condie M,Neklason DW,Burt RW

    更新日期:2008-01-01 00:00:00

  • Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.

    abstract::Nijmegen breakage syndrome is an autosomal recessive disorder caused by biallelic mutation in NBN gene. It is characterized by microcephaly, growth retardation, immuno-deficiency and cancer predisposition. The monoallelic carriers of NBN gene are also reported to be at increased risk of developing various types of mal...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9954-9

    authors: Marafie MJ,Dashti M,Al-Mulla F

    更新日期:2017-07-01 00:00:00

  • Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.

    abstract:PURPOSE:The aim of the present descriptive study was to investigate the experience of sharing genetic information among cancer genetic counselees and their at-risk relatives. METHODS:In total, 147 cancer genetic counselees and 81 of their at-risk relatives answered to a study specific questionnaire and/or were intervi...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9364-3

    authors: Hayat Roshanai A,Lampic C,Rosenquist R,Nordin K

    更新日期:2010-12-01 00:00:00

  • Chemoprevention of familial adenomatous polyposis.

    abstract::Familial adenomatous polyposis (FAP) has always been first and foremost a surgical disease, whose treatment with colectomy has long been known to reduce risk of premature cancer death. The notion of reducing polyp burden and potentially delaying surgical intervention has spawned a host of "chemoprevention" trials. In ...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-016-9901-9

    authors: Lynch PM

    更新日期:2016-07-01 00:00:00

  • Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

    abstract:BACKGROUND:Three mutations in BRCA1 (185delAG 5382InsC) and BRCA2 (6174delT) can be detected in a substantial proportion of Jewish Ashkenazi breast/ovarian cancer families. Family-specific pathogenic mutations in both genes can be detected in up to 5% of high risk Ashkenazim. The contribution of major gene rearrangemen...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-008-9216-6

    authors: Distelman-Menachem T,Shapira T,Laitman Y,Kaufman B,Barak F,Tavtigian S,Friedman E

    更新日期:2009-01-01 00:00:00

  • Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.

    abstract::Microsatellite instability, a well-established driver pathway in colorectal carcinogenesis, can develop in both sporadic and hereditary conditions via different molecular alterations in the DNA mismatch repair (MMR) genes. MMR protein immunohistochemistry (IHC) is currently widely used for the detection of MMR deficie...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-017-0031-9

    authors: Wang T,Stadler ZK,Zhang L,Weiser MR,Basturk O,Hechtman JF,Vakiani E,Saltz LB,Klimstra DS,Shia J

    更新日期:2018-04-01 00:00:00

  • Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations.

    abstract::The myeloproliferative neoplasms (MPN) are clonal, hematological malignancies that include polycythemia vera, essential thrombocythemia and primary myelofibrosis. While most cases of MPN are sporadic in nature, a familial pattern of inheritance is well recognised. The phenotype and status of the commonly acquired JAK2...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-014-9743-2

    authors: Langabeer SE,Haslam K,Linders J,Percy MJ,Conneally E,Hayat A,Hennessy B,Leahy M,Murphy K,Murray M,Ni Ainle F,Thornton P,Sargent J

    更新日期:2014-12-01 00:00:00

  • Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.

    abstract::In the absence of a polyposis phenotype, colorectal cancer (CRC) patients referred for genetic testing because of early-onset disease and/or a positive family history, typically undergo testing for molecular signs of Lynch syndrome in their tumors. In the absence of these signs, DNA testing for germline mutations asso...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-012-9570-2

    authors: Knopperts AP,Nielsen M,Niessen RC,Tops CM,Jorritsma B,Varkevisser J,Wijnen J,Siezen CL,Heine-Bröring RC,van Kranen HJ,Vos YJ,Westers H,Kampman E,Sijmons RH,Hes FJ

    更新日期:2013-03-01 00:00:00

  • Association of MUTYH and MSH6 germline mutations in colorectal cancer patients.

    abstract::Colorectal cancer (CRC) risk associated with germline monoallelic MUTYH mutations remains controversial, although a slightly increased risk for this disease has been suggested. MUTYH and MSH6 proteins act in cooperation during the DNA repair process. Based on this interaction, it was hypothesized that the combination ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9282-4

    authors: Giráldez MD,Balaguer F,Caldés T,Sanchez-de-Abajo A,Gómez-Fernández N,Ruiz-Ponte C,Muñoz J,Garre P,Gonzalo V,Moreira L,Ocaña T,Clofent J,Carracedo A,Andreu M,Jover R,Llor X,Castells A,Castellví-Bel S,Gastrointestinal O

    更新日期:2009-01-01 00:00:00

  • Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia.

    abstract::ACTH independent macronodular adrenal hyperplasia (AIMAH) is a rare disorder characterized by bilateral macronodular hyperplasia of the adrenal glands and increased cortisol production with subclinical or overt Cushing's syndrome. Although the family clustering of AIMAH is infrequent, we have tried our best to find su...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9642-y

    authors: Zhu J,Cui L,Wang W,Hang XY,Xu AX,Yang SX,Dou JT,Mu YM,Zhang X,Gao JP

    更新日期:2013-12-01 00:00:00

  • Lack of germ-line mutations at the specific BRCA1-IRIS coding sequence in 114 Spanish high-risk breast/ovarian families.

    abstract::A new BRCA1 locus product called BRCA1-IRIS has been identified recently. High-risk breast/ovarian families have not been screened for germ-line mutations at the specific BRCA1-IRIS coding sequence, as it was considered merely as part of BRCA1 intron 11. Here we report the first comprehensive screening of germ-line mu...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-005-1236-x

    authors: de la Hoya M,Fernández JM,Sánchez de Abajo A,Tosar A,Díaz-Rubio E,Caldés T

    更新日期:2005-01-01 00:00:00

  • Screening behavior in women at increased familial risk for breast cancer.

    abstract::This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and ...

    journal_title:Familial cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10689-006-0006-8

    authors: Antill YC,Reynolds J,Young MA,Kirk JA,Tucker KM,Bogtstra TL,Wong SS,Dudding TE,Di Iulio JL,Phillips KA

    更新日期:2006-01-01 00:00:00

  • Hepatoblastoma in two siblings and familial adenomatous polyposis: causal nexus or coincidence?

    abstract::Infantile and childhood hepatoblastoma (HB) occurs more frequently in children with hereditary predisposition to familial adenomatous polyposis (FAP) than in the general population. The occurrence of HB in two infant siblings is reported. The sister died of the disease. The brother survived the HB and was later diagno...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9538-2

    authors: Evers C,Gaspar H,Kloor M,Bozukova G,Kadmon M,Keller M,Sutter C,Moog U

    更新日期:2012-09-01 00:00:00

  • The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

    abstract::Following the identification in a proband of a germline BRCA1/BRCA2 mutation in hereditary breast-ovarian cancer (HBOC) or a DNA mismatch repair gene mutation in Lynch syndrome (LS) he or she will be asked to inform at-risk family members about the option for presymptomatic DNA testing. However, in clinical practice m...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-0089-z

    authors: Menko FH,Ter Stege JA,van der Kolk LE,Jeanson KN,Schats W,Moha DA,Bleiker EMA

    更新日期:2019-01-01 00:00:00

  • Microsatellite instability testing in Korean patients with colorectal cancer.

    abstract::Microsatellite instability (MSI) testing is useful for identifying patients with hereditary nonpolyposis colorectal cancer and detecting sporadic colorectal cancer that develops through replication error pathways. A pentaplex panel is recommended by the National Cancer Institute for MSI testing, but simplified mononuc...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9536-4

    authors: Oh JR,Kim DW,Lee HS,Lee HE,Lee SM,Jang JH,Kang SB,Ku JL,Jeong SY,Park JG

    更新日期:2012-09-01 00:00:00

  • Reminders of cancer risk and pain catastrophizing: relationships with cancer worry and perceived risk in women with a first-degree relative with breast cancer.

    abstract::First-degree relatives of women with breast cancer may experience increased worry or perceived risk when faced with reminders of their own cancer risk. Worry and risk reminders may include physical symptoms (e.g., persistent breast pain) and caregiving experiences. Women who engage in pain catastrophizing may be parti...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-0082-6

    authors: Whitney CA,Dorfman CS,Shelby RA,Keefe FJ,Gandhi V,Somers TJ

    更新日期:2019-01-01 00:00:00

  • Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

    abstract::To characterize the frequency of germline mutations associated with Lynch syndrome and review the potential expanded differential diagnoses in very early onset colorectal cancer (CRC) cases without apparent polyposis. Retrospectively reviewed medical records of 96 probands with CRC diagnosed prior to age 36 from three...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9290-4

    authors: Jasperson KW,Vu TM,Schwab AL,Neklason DW,Rodriguez-Bigas MA,Burt RW,Weitzel JN

    更新日期:2010-06-01 00:00:00

  • Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.

    abstract::The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples of cancers from founder populations. We assessed risks of "other cancers" in 268 BRCA1 families and 222 BRCA...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9506-2

    authors: Moran A,O'Hara C,Khan S,Shack L,Woodward E,Maher ER,Lalloo F,Evans DG

    更新日期:2012-06-01 00:00:00

  • Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.

    abstract::Description of the various modalities of breast and ovarian cancer risk management, patient choices and their outcome in a single-center cohort of 158 unaffected women carrying a BRCA1 or BRCA2 germline mutation. Between 1998 and 2009, 158 unaffected women carrying a BRCA1 or BRCA2 gene mutation were prospectively fol...

    journal_title:Familial cancer

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10689-012-9539-1

    authors: This P,de la Rochefordière A,Savignoni A,Falcou MC,Tardivon A,Thibault F,Alran S,Fourchotte V,Fitoussi A,Couturaud B,Dolbeault S,Salmon RJ,Sigal-Zafrani B,Asselain B,Stoppa-Lyonnet D,Institut Curie Breast and Ovarian Cancer

    更新日期:2012-09-01 00:00:00

  • Pain evaluation during gynaecological surveillance in women with Lynch syndrome.

    abstract::To evaluate perceived pain during repetitive annual endometrial sampling at gynaecologic surveillance in asymptomatic women with Lynch syndrome (LS) over time and in addition to symptomatic women without LS, undergoing single endometrial sampling. In this prospective study, 52 women with LS or first degree relatives w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9937-x

    authors: Helder-Woolderink J,de Bock G,Hollema H,van Oven M,Mourits M

    更新日期:2017-04-01 00:00:00

  • Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.

    abstract::Germline mutations in BRCA1 and BRCA2 cause hereditary breast and ovarian cancer. Molecular screening of these two genes in patients with a family history of breast or ovarian cancer has revealed pathogenic variants as well as genetic variants of unknown significance (VUS). These VUS may cause a challenge in the genet...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9916-2

    authors: Jarhelle E,Riise Stensland HM,Mæhle L,Van Ghelue M

    更新日期:2017-01-01 00:00:00

  • Mutations of the SDHB and SDHD genes.

    abstract::The succinate dehydrogenase (SDH) is a mitochondrial enzyme complex with an important role in oxydative phosphorylation and intracellular oxygene sensing and signaling. Mutations in the SDHB (1p35-36) and SDHD subunits (11q23) give rise to the paraganglioma syndromes (PGL), namely PGL 4 and PGL 1, and generate paragan...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-4227-4

    authors: Pawlu C,Bausch B,Neumann HP

    更新日期:2005-01-01 00:00:00

  • Pitfalls in the diagnosis of biallelic PMS2 mutations.

    abstract::Constitutional Mismatch Repair Deficiency (CMMR-D) syndrome is an inherited childhood cancer syndrome due to bi-allelic mutations in one of the four DNA mismatch repair genes involved in Lynch syndrome. The tumor spectrum of this syndrome includes hematological, brain and Lynch syndrome associated malignancies, with a...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-015-9793-0

    authors: Antelo M,Milito D,Rhees J,Roca E,Barugel M,Cuatrecasas M,Moreira L,Leoz ML,Carballal S,Ocaña T,Pellisé M,Castells A,Boland CR,Goel A,Balaguer F

    更新日期:2015-09-01 00:00:00

  • Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.

    abstract:AIM:This study aimed to analyze whether the occurrence of both breast and ovarian cancer in a woman serves as a marker for BRCA gene mutations. MATERIAL AND METHODS:This population-based study included 256 women in western Sweden who developed both invasive breast and ovarian tumors between 1958 and 1999. Archival par...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-006-9101-0

    authors: Einbeigi Z,Bergman A,Meis-Kindblom JM,Flodin A,Bjursell C,Martinsson T,Kindblom LG,Wahlström J,Wallgren A,Nordling M,Karlsson P

    更新日期:2007-01-01 00:00:00

  • Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients.

    abstract::Hereditary non-polyposis colorectal cancer (HNPCC) is one of the most common forms of hereditary colorectal cancer. It is an autosomal dominant disorder resulting from germline mutations in DNA mismatch repair genes. In this study, we screened hMLH1 gene in a group of Iranian HNPCC patients using polymerase chain reac...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9478-2

    authors: Shahmoradi S,Bidmeshkipour A,Salamian A,Emami MH,Kazemi Z,Salehi M

    更新日期:2012-03-01 00:00:00

  • Chemoprevention with special reference to inherited colorectal cancer.

    abstract::Familial Adenomatous Polyposis (FAP) is a model for the adenoma-carcinoma sequence in several respects. One important area in which FAP serves as a model is chemoprevention. Early prevention trials mainly utilized micronutrients and were largely unsuccessful in preventing or causing regression of adenomas. A new era w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9158-4

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00